Recall – Blood culture detection system false negative

Company: BioMerieux SA
Date of Enforcement Report: 10/20/2021
Class II

PRODUCT

MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System

Recall Number: Z-0084-2022

REASON

Under certain conditions, there is a risk for a false negative result.

RECALLING FIRM/MANUFACTURER

BioMerieux SA on 9/2/2021. Voluntary:  Firm Initiated recall is ongoing.

VOLUME OF PRODUCT IN COMMERCE

542 units

DISTRIBUTION

U.S. Nationwide and International

SoftwareCPR Training Courses:

IEC 62304 and other Emerging Standards Impacting Medical Device Software

Being Agile & Yet Compliant

ISO 14971 SaMD Risk Management

Software Risk Management

Medical Device Cybersecurity

Software Verification

IEC 62366 Usability Process and Documentation

Contact Me

Fields marked with an * are required

Or just email training@softwarecpr.com for more info.

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.